While previous studies demonstrate that some PPARγ ligands inhibit growth of multiple carcinoma cell lines [6,15-17], many reports demonstrate that PPARγ ligand-mediated growth inhibition can vary depending on the cancer type. Here, PPARG is linked to cancer.